Clinical Trials · NCT01750086

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption

CompletedPhase 4Teriparatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Massachusetts General Hospital
Enrollment
27
Start date
Jan 2013
Locations
1 site, United States
Primary endpoint
Bone Turnover Marker (Blood Sample)
View Teriparatide compound reference